Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Family of Henrietta Lacks, Whose Unique Cells Changed Science, Settles With Thermo Fisher
What to Read Next Source link
Yellow's Shutdown Could Cost Taxpayers Money
Whether the federal government recovers the money it lent Yellow at the height of the pandemic would likely depend on how much Yellow raises by
Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease
Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle another disease: a rare autoimmune condition that
Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall
The company is rolling out 19 products or new uses within 18 months, CEO Albert Bourla said. Source link
‘I Don’t Want to Be Here Anymore.’ The Economic Cost of Houston’s Heat.
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.
Facebook Bowed to White House Pressure, Removed Covid Posts
Internal Meta emails say pressure from Washington was behind a decision to take down posts attributing the pandemic to a man-made virus. Source link
U.K. Reviews Safety of Ozempic, Other Weight-Loss Drugs
Drug regulators said they have received several reports of suspected suicidal and self-injurious behavior in patients taking the drugs. Source link
Meta’s Threads Isn’t Labeling Propaganda Accounts From Russia, China State Media
What to Read Next Source link
Biogen to Cut Roughly 11% of Workforce
The biotech cited the launch of Alzheimer’s drug Leqembi as part of its new focus on big-return products. Source link
The Hidden Career Cost of Being Overweight
New moves to outlaw weight discrimination are pushing companies to examine one of the most insidious forms of on-the-job bias. Source link
